State-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis

Christopher R Polage1, Stuart H Cohen2

  • 1Departments of Pathology and Laboratory Medicine, University of California, Davis, School of Medicine, Sacramento, California, USA Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, School of Medicine, Sacramento, California, USA crpolage@ucdavis.edu.

Insights

Diagnosing meningitis and encephalitis is crucial but challenging due to various causes and testing limitations. New molecular tests show promise for improving diagnostic accuracy in these serious infections.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Meningitis and encephalitis are severe conditions with diverse etiologies, including infectious, postinfectious, and noninfectious causes.
  • Accurate diagnosis is vital for effective treatment and prognosis, yet many cases remain undiagnosed.
  • Suboptimal testing and the absence of tests for all potential pathogens present significant diagnostic barriers.

Purpose of the Study:

  • To review the epidemiology of meningitis and encephalitis in developed countries.
  • To identify current barriers to accurate diagnosis.
  • To discuss the best available diagnostic tests and emerging technologies.

Main Methods:

  • Literature review and synthesis of current diagnostic strategies for meningitis and encephalitis.
  • Analysis of epidemiological data and diagnostic challenges in developed nations.
  • Evaluation of established and novel testing methodologies.

Main Results:

  • Significant challenges exist in diagnosing meningitis and encephalitis, leading to a substantial number of undiagnosed cases.
  • Current diagnostic approaches are limited by test availability and suboptimal performance for certain pathogens.
  • Emerging technologies like multiplex panels and metagenomic sequencing offer potential improvements.

Conclusions:

  • Improving diagnostic yield for meningitis and encephalitis requires addressing current testing limitations.
  • Novel molecular diagnostic methods are expected to revolutionize the diagnostic landscape for these conditions.
  • Enhanced diagnostic strategies are essential for timely and appropriate patient management.